• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Virol . Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemic

tetano

Editor, Senior Moderator
Arch Virol


. 2021 Feb 12.
doi: 10.1007/s00705-021-04976-5. Online ahead of print.
Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemic


Akeno Tsuneki-Tokunaga[SUP] 1 2 [/SUP], Kyosuke Kanai[SUP] 1 2 [/SUP], Asao Itagaki[SUP] 1 2 [/SUP], Hideaki Tsuchie[SUP] 2 3 [/SUP], Takayoshi Okada[SUP] 2 4 [/SUP], Masaaki Kasagi[SUP] 2 5 [/SUP], Kiyoshi Tanaka[SUP] 2 6 [/SUP], Miho Aoki[SUP] 1 [/SUP], Alfredo Jr A Hinay[SUP] 1 [/SUP], Seiji Kageyama[SUP] 7 8 [/SUP]



Affiliations

Abstract

The correlation of viral growth capability (n = 156) with the viral load in nasopharyngeal swabs (n = 76) was assessed. Epidemic influenza A/H1N1, A/H3N2, and B viruses showed a wide range of growth capability (10[SUP]4[/SUP]-10[SUP]11[/SUP] copies/mL) in Madin-Darby canine kidney cells. The growth was correlated with the nasopharyngeal viral load (r = 0.53). Six selected strains showed growth-dependent cell death (r = 0.96) in a growth kinetics assay. Epidemic influenza viruses exhibit a wide range of growth capability. Growth capability should be considered one of the key factors in disease prognosis.
 
Back
Top Bottom